Overall, our results demonstrated that Viscosol exhibits anti-inflammatory activity by reversing the NLRP3 and AIM2-mediated inflammation in diabetic neuro and nephropathy, thus making it a potent therapeutic drug for the treatment of diabetes-linked pathophysiology. Here, AIM2 is linked to Nephropathy.